Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
What It Targets Our AOD-9604 peptides are designed to target: Stubborn body fat and slow fat loss in clients already working on nutrition, steps, and strength training. Mild to moderate central adiposity where clients want incremental support rather than a primary weight-loss medication. Clients who cannot or do not wish to use GLP1s but still want to explore peptide-based metabolic support under a transparent riskbenefit discussion. Aesthetic-focused body recomposition journeys where even small improvements in fatmuscle balance can enhance contouring results
Human efficacy data are limited
Fu, J., Guo, O., Zhen, Z
Thankfully I already had some supplies and knew how to inject
GHK-Cu is a copper-binding tripeptide investigated in connective-tissue and matrix-remodeling models
Pipeline Disclosure: Retatrutide Phase 3 Trials
US$ 22.33
US$ 24.05
US$ 25.76
US$ 28.19
US$ 23.45
